Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enerisant (TS-091) in Narcolepsy
NCT03267303Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Enerisant in narcolepsy, sponsored by Taisho Pharmaceutical. Started Oct 2017; status: completed.
02
Drugs
Enerisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT03267303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03267303.